• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多国原位导管癌(DCIS)队列中的肿瘤浸润淋巴细胞。

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.

作者信息

Badve Sunil S, Cho Sanghee, Lu Xiaoyu, Cao Sha, Ghose Soumya, Thike Aye Aye, Tan Puay Hoon, Ocal Idris Tolgay, Generali Daniele, Zanconati Fabrizio, Harris Adrian L, Ginty Fiona, Gökmen-Polar Yesim

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.

Winship Cancer Institute, Atlanta, GA 30322, USA.

出版信息

Cancers (Basel). 2022 Aug 13;14(16):3916. doi: 10.3390/cancers14163916.

DOI:10.3390/cancers14163916
PMID:36010908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406008/
Abstract

Tumor-infiltrating lymphocytes (TILs) are prognostic in invasive breast cancer. However, their prognostic significance in ductal carcinoma in situ (DCIS) has been controversial. To investigate the prognostic role of TILs in DCIS outcome, we used different scoring methods for TILs in multi-national cohorts from Asian and European women. Self-described race was genetically confirmed using QC Infinium array combined with radmixture software. Stromal TILs, touching TILs, circumferential TILs, and hotspots were quantified on H&E-stained slides and correlated with the development of second breast cancer events (BCE) and other clinico-pathological variables. In univariate survival analysis, age older than 50 years, hormone receptor positivity and the presence of circumferential TILs were weakly associated with the absence of BCE at the 5-year follow-up in all cohorts (p < 0.03; p < 0.02; and p < 0.02, respectively, adjusted p = 0.11). In the multivariable analysis, circumferential TILs were an independent predictor of a better outcome (Wald test p = 0.01), whereas younger age was associated with BCE. Asian patients were younger with larger, higher grade, HR negative DCIS lesions, and higher TIL variables. The spatial arrangement of TILs may serve as a better prognostic indicator in DCIS cases than stromal TILs alone and may be added in guidelines for TILs evaluation in DCIS.

摘要

肿瘤浸润淋巴细胞(TILs)对浸润性乳腺癌具有预后价值。然而,它们在导管原位癌(DCIS)中的预后意义一直存在争议。为了研究TILs在DCIS预后中的作用,我们对来自亚洲和欧洲女性的多国队列中的TILs使用了不同的评分方法。使用QC Infinium阵列结合radmixture软件对自我描述的种族进行基因确认。在苏木精和伊红(H&E)染色的切片上对基质TILs、接触性TILs、周边TILs和热点进行定量,并与第二原发性乳腺癌事件(BCE)的发生以及其他临床病理变量相关联。在单变量生存分析中,所有队列中年龄大于50岁、激素受体阳性以及存在周边TILs与5年随访时无BCE的情况呈弱相关(p < 0.03;p < 0.02;以及p < 0.02,调整后p = 0.11)。在多变量分析中,周边TILs是预后较好的独立预测因素(Wald检验p = 0.01),而年龄较小与BCE相关。亚洲患者年龄较小,DCIS病变更大、分级更高、激素受体阴性,且TIL变量更高。与单独的基质TILs相比,TILs的空间排列可能是DCIS病例中更好的预后指标,并且可能会被纳入DCIS中TILs评估的指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/91775c23a103/cancers-14-03916-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/0d84809f6d64/cancers-14-03916-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/fa0ccfbc45eb/cancers-14-03916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/91775c23a103/cancers-14-03916-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/0d84809f6d64/cancers-14-03916-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/fa0ccfbc45eb/cancers-14-03916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1d/9406008/91775c23a103/cancers-14-03916-g003.jpg

相似文献

1
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.多国原位导管癌(DCIS)队列中的肿瘤浸润淋巴细胞。
Cancers (Basel). 2022 Aug 13;14(16):3916. doi: 10.3390/cancers14163916.
2
Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.导管原位癌(DCIS)中浸润淋巴细胞的评估——三种不同方法学的评估及与 Oncotype DX DCIS 评分的相关性。
Histopathology. 2020 Nov;77(5):749-759. doi: 10.1111/his.14181. Epub 2020 Sep 26.
3
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.肿瘤浸润淋巴细胞对乳腺导管原位癌的预后意义。
Mod Pathol. 2018 Aug;31(8):1226-1236. doi: 10.1038/s41379-018-0040-8. Epub 2018 Mar 20.
4
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.乳腺导管原位癌中免疫微环境的预后意义。
Br J Cancer. 2020 May;122(10):1496-1506. doi: 10.1038/s41416-020-0797-7. Epub 2020 Mar 17.
5
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.肿瘤浸润淋巴细胞分析揭示了原位乳腺导管癌的两个新的生物学不同亚群。
BMC Cancer. 2018 Feb 3;18(1):129. doi: 10.1186/s12885-018-4013-6.
6
Touching tumour-infiltrating lymphocytes in low-risk ductal carcinoma in situ (DCIS) correlate with upgrading to high-grade DCIS.低危型乳腺导管原位癌(DCIS)中浸润淋巴细胞的检出与向高级别 DCIS 升级相关。
Histopathology. 2022 Jan;80(2):291-303. doi: 10.1111/his.14539. Epub 2021 Sep 22.
7
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.肿瘤浸润淋巴细胞为低风险导管原位癌患者增加预后信息:来自瑞典导管原位癌随机放疗试验的结果
Eur J Cancer. 2022 Jun;168:128-137. doi: 10.1016/j.ejca.2022.01.016. Epub 2022 Feb 27.
8
Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ.肿瘤浸润淋巴细胞对导管原位癌的预后及预测意义
Oncoimmunology. 2021 Mar 18;10(1):1875637. doi: 10.1080/2162402X.2021.1875637.
9
Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).肿瘤浸润淋巴细胞在当代女性导管原位癌(DCIS)队列中的作用。
Ann Surg Oncol. 2019 Oct;26(10):3337-3343. doi: 10.1245/s10434-019-07562-x. Epub 2019 Jun 25.
10
Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis.肿瘤浸润淋巴细胞在 DCIS 中的预后价值:一项荟萃分析。
BMC Cancer. 2022 Jul 18;22(1):782. doi: 10.1186/s12885-022-09883-9.

引用本文的文献

1
The Microenvironment in DCIS and Its Role in Disease Progression.导管原位癌中的微环境及其在疾病进展中的作用。
Adv Exp Med Biol. 2025;1464:211-235. doi: 10.1007/978-3-031-70875-6_12.
2
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model.使用生成对抗网络增强深度学习模型预测导管原位癌(DCIS)中的乳腺癌事件
Cancers (Basel). 2023 Mar 23;15(7):1922. doi: 10.3390/cancers15071922.

本文引用的文献

1
Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.夏威夷女性导管原位癌浸润性第二乳腺癌发生率的种族和民族差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2128977. doi: 10.1001/jamanetworkopen.2021.28977.
2
Genomic Alterations during the to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.免疫系统塑造的从导管原位癌到浸润性导管乳腺癌的基因组改变。
Mol Cancer Res. 2021 Apr;19(4):623-635. doi: 10.1158/1541-7786.MCR-20-0949. Epub 2020 Dec 18.
3
Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.
种系APOBEC3B缺失增加了亚洲乳腺癌中的体细胞超突变,这与Her2亚型、PIK3CA突变和免疫激活相关。
Int J Cancer. 2021 May 15;148(10):2489-2501. doi: 10.1002/ijc.33463. Epub 2021 Jan 22.
4
The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences.亚洲乳腺癌的分子图谱揭示了具有临床相关性的人群特异性差异。
Nat Commun. 2020 Dec 22;11(1):6433. doi: 10.1038/s41467-020-20173-5.
5
Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?阴茎癌行阴茎部分切除术治疗后局部复发的预测因素及其对生存的影响:是否需要挑战传统观念?
BJU Int. 2021 May;127(5):606-613. doi: 10.1111/bju.15297. Epub 2020 Nov 27.
6
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma .肿瘤浸润淋巴细胞(TILs)与导管癌后二次乳腺事件风险
Front Oncol. 2020 Aug 19;10:1486. doi: 10.3389/fonc.2020.01486. eCollection 2020.
7
Identifying risk factors for mortality among patients previously hospitalized for a suicide attempt.识别先前因自杀未遂住院的患者的死亡风险因素。
Sci Rep. 2020 Sep 16;10(1):15223. doi: 10.1038/s41598-020-71320-3.
8
Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.导管原位癌(DCIS)中浸润淋巴细胞的评估——三种不同方法学的评估及与 Oncotype DX DCIS 评分的相关性。
Histopathology. 2020 Nov;77(5):749-759. doi: 10.1111/his.14181. Epub 2020 Sep 26.
9
Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.早期肺腺癌中新型复发相关免疫特征的临床意义及炎症图谱。
Cancer Lett. 2020 Jun 1;479:31-41. doi: 10.1016/j.canlet.2020.03.016. Epub 2020 Mar 19.
10
Higher densities of tumour-infiltrating lymphocytes and CD4 T cells predict recurrence and progression of ductal carcinoma in situ of the breast.肿瘤浸润淋巴细胞和 CD4 T 细胞密度较高,预示着乳腺导管原位癌的复发和进展。
Histopathology. 2020 May;76(6):852-864. doi: 10.1111/his.14055.